This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


HanAll Biopharma Co., Ltd.

Drug Names(s): HL-008, amlodipine (Norvasc)/losartan (Cozaar)

Description: HL008 combination product is composed of losartan (Cozaar), an angiotensin II receptor antagonist, and amlodipine (Norvasc), a calcium channel blocker (CCB).

HL008 News

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug